financetom
Business
financetom
/
Business
/
Exponent Insider Sold Shares Worth $415,380, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Exponent Insider Sold Shares Worth $415,380, According to a Recent SEC Filing
Jul 31, 2024 9:19 AM

11:54 AM EDT, 07/31/2024 (MT Newswires) -- John Pye, Group Vice President, on July 30, 2024, sold 3,956 shares in Exponent (EXPO) for $415,380. Following the Form 4 filing with the SEC, Pye has control over a total of 28,422 shares of the company, with 28,422 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/851520/000085152024000106/xslF345X03/edgardoc.xml

Price: 106.43, Change: -0.53, Percent Change: -0.50

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Consolidated Edison to Sell Stake in Pipeline to Ares Management for $357.5 Million
Consolidated Edison to Sell Stake in Pipeline to Ares Management for $357.5 Million
Nov 25, 2025
04:11 AM EST, 11/25/2025 (MT Newswires) -- Consolidated Edison ( ED ) said in a regulatory filing late Monday that it agreed to sell its 6.6% interest in Mountain Valley Pipeline to an Ares Management ( ARES ) fund for $357.5 million. The deal is expected to close in H1 2026, subject to the potential exercise of rights by the...
Pony AI's Q3 Non-GAAP Loss Narrows, Revenue Increases; Shares Rise Pre-Bell
Pony AI's Q3 Non-GAAP Loss Narrows, Revenue Increases; Shares Rise Pre-Bell
Nov 25, 2025
04:26 AM EST, 11/25/2025 (MT Newswires) -- Pony AI (PONY) reported a Q3 non-GAAP net loss Tuesday of $0.14 per diluted share, compared with a loss of $3.50 a year earlier. Analysts' estimates were not readily available for comparison. Revenue for the quarter ended Sept. 30 was $25.4 million, up from $14.8 million a year earlier. A single analyst surveyed...
Regeneron, Sanofi Say EU Approves Dupixent for Inflammatory Skin Disease
Regeneron, Sanofi Say EU Approves Dupixent for Inflammatory Skin Disease
Nov 25, 2025
04:12 AM EST, 11/25/2025 (MT Newswires) -- Regeneron Pharmaceuticals ( REGN ) and Sanofi ( SNY ) said Tuesday the European Commission has authorized Dupixent, or dupilumab, for certain adults and adolescents aged 12 years and above with moderate-to-severe chronic spontaneous urticaria. The approval covers patients with inadequate response to histamine-1 antihistamines and who are naive to anti- immunoglobulin-E therapy...
Invest Green Acquisition Prices $150 Million IPO
Invest Green Acquisition Prices $150 Million IPO
Nov 25, 2025
04:14 AM EST, 11/25/2025 (MT Newswires) -- Invest Green Acquisition Corporation (IGAC) said Tuesday it priced its initial public offering of 15 million units at $10 each for gross proceeds of $150 million. Invest Green granted underwriters a 45-day option to buy up to roughly 2.3 million additional units at the IPO price to cover any over allotments, the company...
Copyright 2023-2026 - www.financetom.com All Rights Reserved